COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.


This series of 90-minute webinars features Mayo Clinic experts discussing monoclonal antibodies and other novel therapeutics in COVID-19 treatment. Webinar recordings will be available within 48 hours.  Additional COVID-19 online education and resources are also available.  

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Modeling and Forecasting of the COVID-19 Pandemic

On Tuesday, April 12, from 12:00 p.m. – 1:30 p.m., ET, Mayo Clinic and other experts discuss conceptual frameworks for pandemic modeling and predictions and challenges faced predicting the spread of COVID-19. Unique modeling and forecasting aspects, opportunities, developments, and lessons learned also are covered.

Moderator: Ravindra V. Durvasula, M.D., division chair, Division of Infectious Diseases
Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases
Featured expert: Aleksandr Y. Aravkin, Ph.D., adjunct assistant professor, Applied Mathematics, University of Washington

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

COVID-19 Small Molecule Drug Discovery

On Tuesday, February 22, from 12:00 p.m. – 1:30 p.m. ET, Mayo Clinic and other experts discuss the challenges and opportunities of small molecule drug discovery and treatments to disrupt viral progression of SARS-CoV-2. The state of the art in antivirals to treat COVID-19 will also be reviewed.

  • Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases
  • Moderator: Ravindra V. Durvasula, M.D., senior associate consultant, Division Chair of Infectious Diseases 
  • Featured Expert: Thomas Caulfield, Ph.D., senior associate consultant, Division of Neuroscience
  • Featured Expert: Daniel P. Becker, Ph.D., Department of Chemistry & Biochemistry, Loyola University Chicago

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Updates on COVID-19 Variants of Concern, Vaccines, and Long Haulers

On Tuesday, January 11, from 12:00 p.m. – 1:30 p.m., ET, Mayo Clinic and other experts discuss the latest information on the impact of SARS-CoV-2 variants, vaccine and treatment updates, and implications for long haulers.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Featured expert: Isabel C. Mira-Avendano, M.D., Associate Professor of Medicine, Divisions of Critical Care, Pulmonary and Sleep, Director of the Post-COVID Center of Excellence, Co-Director Interstitial Lung Disease Center, UT Health. The University of Texas Health Science Center at Houston-McGovern Medical School 
  • Featured expert:  Abinash Virk, M.D., consultant, Division of Infectious Diseases; professor of medicine

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Global COVID-19 Pandemic Updates Part Two: India

On Tuesday, December 7, from 12:00 p.m. – 1:30 p.m., ET, Mayo Clinic and other experts continue a discussion on the global impact of COVID-19. Infection prevalence, virus variants, preventative measures, vaccination status, and therapies used in treating patients in India will be addressed along with the prevalence of other infectious diseases.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases
  • Featured expert: Pulin Kumar Gupta, M.D., professor medicine in charge, HIV/ART Centre ABVIMS (formerly PFIMER), Dr. Ram Manohar Lohia Hospital, New Delhi, India

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Global COVID-19 Pandemic Updates Part One: Kenya and Ghana

On Tuesday, November 16from 12:00 p.m. to 1:30 p.m. ET Mayo Clinic and other experts discuss COVID-19 infection prevalence, virus variants, preventative measures, vaccination status, and therapies used in treating patients in Kenya and Ghana. Additionally, impact on the prevalence of HIV, tuberculosis, and malaria will be explored.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases
  • Featured expert: Kwadwo Asamoah Kusi, PhD, senior research fellow, Department of Immunology; Head Department of Electron Microscopy & Histopathology, NMIMR, College of Health Sciences, University of Ghana, Legon
  • Featured expert: Bernhards Ogutu, M.D., chief research officer, Kenya Medical Research Institute (KEMRI); senior clinical trialist, Malaria Clinical Trials, Alliance of the INDEPTH-Network; director, Centre for Research in Therapeutic Sciences (CREATES), Strathmore University, Nairobi

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Update on SARS-CoV-2 Variants of Concern and Vaccines; Implications for SOT Recipients

On Tuesday, October 12, from 12:00 p.m. to 1:30 p.m. ET, Mayo Clinic experts discuss the latest information on the SARS-CoV-2 delta variant’s impact on vaccine recommendations for the general population and for solid-organ transplant recipients. Additional topics will include breakthrough infections in normal versus immunocompromised hosts and the most current vaccine updates.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Featured Expert: Gregory A. Poland, M.D., emeritus consultant, Division of General Internal Medicine; Mary Lowell Leary Emeritus Professor of Medicine; director, Mayo Vaccine Research Group
  • Featured Expert: Sadia Z. Shah, M.D., M.B.A., consultant, Division of Pulmonary Medicine; interim medical director, Lung Transplant Program, Mayo Clinic in Arizona; assistant professor of medicine

Learning Objectives

Upon completion of this activity, you will be able to:

  • Describe the current global epidemiology of SARS CoV-2 variants
  • Define breakthrough infections including immunosuppressed populations
  • Discuss the best strategies for managing immunocompromised groups if not responsive to vaccines
  • Discuss the importance of 3rd vaccine dose given to the immunocompromised and over 65 age groups
  • Describe therapies locally used for treating COVID-19 patients in Kenya and Ghana
  • Give examples of preventive measures implemented by the government agencies or medical societies
  • Describe vaccination status: availability of types, second of mRNA doses access and impact on other vaccines in Kenya and Ghana
  • Describe the current status of COVID-19 pandemic in Eastern and Western Africa

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Commercial Support

This educational activity is supported in part by an
independent medical education grant from

Pfizer, Inc.

and is in accordance with ACCME guidelines.